This is The Marshall Project’s Closing Argument newsletter, a weekly deep dive into a key criminal justice issue. Want this delivered to your inbox? Sign up for future newsletters. April Lee was still ...

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists were initially developed to treat diabetes and obesity, but research shows significant promise as a novel therapy for various addictive disorders, ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...

Drug abuse and drug addiction are related but not the same. Drug abuse describes using legal or illegal substances in a way that is harmful, whereas drug addiction is a physical or psychological ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

Despite fewer new addiction cases worldwide, a sweeping analysis finds drug-related deaths surging, exposing critical failures in global harm-reduction and recovery systems. Study: The evolving burden ...

People often joke that their favorite snack is “like crack” or call themselves “chocoholics” in jest. But can someone really be addicted to food in the same way they could be hooked on substances such ...